Table 1.

Alzheimer’s disease drugs approved for medical use.

Drug	Primary Action Included	Reference
Rivastigmine	Cholinesterase inhibition	[351]
Galantamine		[352]
Donepezil		[352]
Memantine	Blockade of NMDA receptor	[353]
Aducanumab *	Monoclonal antibody directed at brain Aβ plaques and oligomers	[349]

Aβ—amyloid beta; NMDA—N-methyl-d-aspartate. * Approved for medical use in the United States by the Food and Drug Administration in 2021.